New York, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Chronic Obstructive Pulmonary Disease (COPD) Drugs in Development by Stages, Target, MoA, RoA, ...
An experimental COPD drug from AstraZeneca could prove competitive with existing treatments, and have a slice of the market ...
Inhaled chronic obstructive pulmonary disease (COPD) medications prescribed before surgery in patients with early-stage non–small cell lung cancer (NSCLC) were associated with both short- and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results